Who is sponsoring DCP;DAP?

DCP;DAP is sponsored by Jinnah Postgraduate Medical Centre.

What condition does DCP;DAP study?

DCP;DAP studies Pemphigus Vulgaris.

What drugs are being tested in DCP;DAP?

Interventions: Dexamethasone Cyclophosphamide Pulse therapy, Dexamethasone Azathioprine Pulse therapy.

What is the status of DCP;DAP?

DCP;DAP is currently COMPLETED.

Last reviewed 2025-02-28 · How we verify

Comparing DCP and DAP for Pemphigus Vulgaris (DCP;DAP)

NCT06846255 PHASE4 COMPLETED

What's the study about? This study focused on comparing two different treatments for pemphigus vulgaris, a skin condition caused when body's immune system works against itself. The treatments were dexamethasone cyclophosphamide pulse (DCP) therapy and dexamethasone azathioprine pulse (DAP) therapy. Why was this study done? The goal of the study was to determine which treatment, DCP or DAP, was more effective in treating pemphigus vulgaris. Both treatments involve high-dose steroids combined with other medications, but they differ in the specific medications used. How did they do the study? Researchers conducted a randomized controlled trial, where patients were randomly assigned to receive either DCP or DAP therapy. They then followed these patients to see how well each treatment worked.

Details

Lead sponsor	Jinnah Postgraduate Medical Centre
Phase	PHASE4
Status	COMPLETED
Enrolment	66
Start date	Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Pemphigus Vulgaris

Interventions

Dexamethasone Cyclophosphamide Pulse therapy
Dexamethasone Azathioprine Pulse therapy

Countries

Pakistan